Skip to content
Journey Medical Corporation logo

Journey Medical Corporation

DERM

Journey Medical Corporation is a commercial-stage pharmaceutical company specializing in the acquisition, development, and commercialization of prescription drugs for dermatological conditions.

Market cap
$192.74M+14.6%
Revenue$64.7M+15.0%
Net income-$9.6M+52.7%
EPS (diluted)-$0.37+63.0%
Trailing twelve months · change vs. prior year

Earnings

Next report

Aug 11, 2026 (in a month)
Revenue estimate$18.4M
EPS estimate-$0.01

Financials

Q1 2026

Income statement

See full
Revenue$16.0M+21.5%
Gross profit$9.7M+16.7%
Operating income-$1.5M+55.1%
Net income-$2.2M+45.2%
EPS (diluted)-$0.08+55.6%

Balance sheet

See full
Cash & equivalents$27.2M+29.2%
Total debt$25.5M+1.2%
Total equity$30.8M+43.1%
Total assets$91.5M+7.7%

Cash flow

See full
Operating cash flow$2.9M+203%

Valuation & ratios

Valuation

See full
Market cap$192.74M+14.6%
Enterprise value$190.99M+14.9%
P/S+0.1×

Profitability

See full
Gross margin65.4%-1.0pp
Operating margin-9.8%
Net margin-14.8%

Returns & leverage

See full
Return on equity-36.6%
Debt / equity0.8×-0.3×
Current ratio1.7×+0.4×

Segments

By product

See full
Emrosi$6.3M+202%
Qbrexza$5.0M-2.6%
Accutane$3.3M-9.3%
Foam Franchise Products Amzeeq Zilxi$1.1M
Other Legacy$277.0K-61.9%

By segment

See full
Dermatological$16.0M+21.5%

Competitors

Profile

Journey Medical Corporation is a commercial-stage pharmaceutical company specializing in the acquisition, development, and commercialization of prescription drugs for dermatological conditions. The company leverages a dedicated field sales organization to market a portfolio of FDA-approved treatments in the United States, focusing on addressing unmet needs in skin health.

Competitive position

A commercial-stage specialty pharmaceutical firm focused on niche dermatological markets through strategic licensing and a dedicated sales force.

GeographiesUnited States
Customer segmentsMedical Professionals, Specialty Pharmacies
Business modelProduct Licensing, Direct Sales, Research and Development
SuppliersPharmaceutical Research and Development, Contract Manufacturing Organizations, FDA Regulatory Approval
CustomersSpecialty Pharmacies, Wholesale Drug Distributors, Dermatology Clinics
Listed2021
Employees58.0
CEOClaude Maraoui
FilingsSEC EDGAR

Questions, answered.

What is Journey Medical Corporation's market cap?
Journey Medical Corporation (DERM) has a market capitalization of $192.7M and trades on NASDAQ.
What is Journey Medical Corporation's revenue and profitability?
Journey Medical Corporation generated $64.7M in trailing twelve-month revenue with a net loss of $9.6M, representing a net margin of -14.8%. Gross margin stands at 65.4%. These figures are based on the Q1 2026 filing.
Who are Journey Medical Corporation's competitors?
Journey Medical Corporation's key competitors include Bausch Health Companies Inc., Fortress Biotech, Inc., Pelthos Therapeutics Inc., and others. These companies compete in similar markets and product categories.
Who does Journey Medical Corporation partner with?
Journey Medical Corporation's notable partners include Dr. Reddy’s Laboratories, Ltd..
What subsidiaries does Journey Medical Corporation have?
Journey Medical Corporation's subsidiaries include Fortress Biotech, Inc..
Where is Journey Medical Corporation headquartered?
Journey Medical Corporation is headquartered in United States of America and employs approximately 58 people. It has been publicly traded since 2021.